✦ LIBER ✦

473: Cost-effectiveness of compounded versus commercially manufactured 17-alpha hydroxyprogesterone caproate (17P) for the prevention of recurrent preterm birth

✍ Scribed by Thompson, Jennifer; Grotegut, Chad; Murtha, Amy; Myers, Evan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Does administration of 17 alpha-hydroxyp

✍ Andrei Rebarber; Niki Istwan; Karen Russo-Stieglitz; Larry Rand; Debbie Rhea; Ga 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 76 KB

17-alpha-hydroxyprogesterone caproate fo

✍ Vincenzo Berghella; Dana Figueroa; Jeff M. Szychowski; John Owen; Gary D.V. Hank 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 499 KB

9: 17-Alpha-hydroxyprogesterone caproate

✍ Vincenzo Berghella; Dana Figueroa; Jeff Szychowski 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 360 KB

462: Effectiveness and barriers for the

✍ Baha Sibai; Helen How; Ronnie Horner; Karthikeyan Meganathan 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 205 KB

38: The relationship between polymorphis

✍ Tracy Manuck 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 43 KB